Update on pathological gambling

Current Psychiatry Reports

Volumn 8, Issue 1, 2006, Pages 53-58

  Grant, Jon E ^a   Williams, Kyle A ^b   Kim, Suck Won ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; FLUVOXAMINE; LITHIUM CARBONATE; NALMEFENE; NALTREXONE; OLANZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADDICTION; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DRUG MECHANISM; GENETIC SUSCEPTIBILITY; HUMAN; MEDICAL RESEARCH; MENTAL DISEASE; META ANALYSIS; MORTALITY; MOTIVATION; NEUROBIOLOGY; NEUROIMAGING; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PATHOPHYSIOLOGY; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; PUBLIC HEALTH; REVIEW; REWARD; SYSTEMATIC REVIEW;

EID: 33645079401     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-006-0081-4     Document Type: Review

References (46)

1. Shaffer HJ, Hall MN: Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health 1999, 89:1369-1376.
2. Argo T, Black DW: Clinical characteristics. In Pathological Gambling: A Clinical Guide to Treatment. Edited by Grant JE, Potenza MN. Washington, DC: APPI; 2004:39-53.
3. Grant JE, Potenza MN: Pathological gambling and other behavioral addictions. In Clinical Textbook of Addictive Disorders, Third Edition. Edited by Frances RJ, Miller SI, Mack AH. New York: Guildford Press; 2005:303-320.
4. Blanco C, Moreyra P, Nunes EV, et al.: Pathological gambling: addiction or compulsion? Semin Clin Neuropsychiatry 2001, 6:167-176.
5. King JA, Tenney J, Rossi V, et al.: Neural substrates underlying impulsivity. Ann N Y Acad Sci 2003, 1008:160-169.
6. Martin PR, Petry NM: Are non-substance-related addictions really addictions? Am J Addict 2005, 14:1-7.
7. Phillips KA: The obsessive-compulsive spectrums. Psychiatr Clin North Am 2002, 25:791-809.
8. Lucki I: The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998, 44:151-162.
9. Melis M, Spiga S, Diana M: The dopamine hypothesis of drug addiction: hypodopaminergic state. Int Rev Neurobiol 2005, 63:101-154.
10. Hyman SE: Addiction: a disease of learning and memory. Am J Psychiatry 2005, 162:14-22.
11. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
12. Nader MA, Czoty PW: PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. Am J Psychiatry 2005, 162:73-82.
13. Kelley AE: Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 2004, 44:161-179.
14. Kalivas PW, Volkow ND: The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005, 162:03-13.
15. Di Chiara G: The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 1995, 38:95-137.
16. Schultz W: Getting formal with dopamine and reward. Neuron 2002, 36:241-263.
17. Tobler PN, Fiorillo CD, Schultz W: Adaptive coding of reward by dopamine neurons. Science 2005, 307:1642-1645.
18. Fiorillo CD, Tobler PN, Schultz W: Discrete coding of reward probability and uncertainty by dopamine neurons. Science 2003, 299:1898-1902.
19. Dreher IC, Kohn P, Berman KF: Neural coding of distinct statistical properties of reward information in humans. Cereb Cortex 2005, In press.
20. Crockford DN, Goodyear B, Edwards J, et al.: Cue-induced brain activity in pathological gamblers. Biol Psychiatry 2005, 58:787-795.
21. Reuter J, Raedler T, Rose M, et al.: Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005, 8:7-8.
22. Potenza MN, Leung HC, Blumberg HP, et al.: An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry 2003, 160:1990-1904.
23. Breiter HC, Aharon I, Kahneman D, et al.: Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron 2001, 30:619-639.
24. Breiter HC, Gollub RL, Weisskoff RM, et al.: Acute effects of cocaine on human brain activity and emotion. Neuron 1997, 19:591-611.
25. Breiter HC, Becerra L, Gonzalez RG: Morphine induced reward and pain circuitry activation in drug naïve humans [poster abstract]. Paper presented at American Pain Society, Atlanta, GA: 2000.
26. Jentsch JD, Taylor JR: Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999, 6:373-390.
27. Goldstein RZ, Volkow ND: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for involvement of the frontal cortex. Am J Psychiatry 2002, 999:523-528.
28. Volkow ND, Wang G-J, Ma Y, et al.: Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 2003, 23:161-168.
29. Wexler BE, Gottshalk CH, Fulbright RK, et al.: Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 2001, 158:86-95.
30. Petry NM, Stinson FS, Grant BF: Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2005, 66:564-574.
31. Shah KR, Potenza MN, Eisen SA: Biological basis for pathological gambling. In Pathological Gambling: A Clinical Guide to Treatment. Edited by Grant JE, Potenza MN. Washington, DC; APPI; 2004.
32. Dodd ML, Klos KJ, Bower JH, et al.: Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005, 62:1377-1381.
33. Hollander E, DeCaria CM, Finkell JN, et al.: A randomized double-blind fluvox- amine/placebo crossover trial in pathological gambling. Biol Psychiatry 2000, 47:813-817.
34. Blanco C, Petkova E, Ibanez A, et al.: A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 2002, 14:9-15.
35. Kim SW, Grant JE, Adson DE, et al.: A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002, 63:501-507.
36. Grant JE, Kim SW, Potenza MN, et al.: Paroxetine treatment of pathological gambling: A multi-center randomized controlled trial. Int Clin Psychopharmacol 2003, 18:243-249.
37. Saiz-Ruiz J, Blanco C, Ibnaez A, et al.: Sertraline treatment of pathological gambling: a pilot study. J Clin Psychiatry 2005, 66:28-33.
38. Potenza MN: The neurobiology of pathological gambling. Semin Clin Neuropsychiatry 2001, 6:217-226.
39. Hollander E, Pallanti S, Allen A, et al.: Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 2005, 162:137-145.
40. Kim SW, Grant JE, Adson D, Shin YC: Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001, 49:914-921.
41. Grant JE, Potenza MN, Hollander E, et al.: A multicenter investigation of fixed-dose nalmefene in the treatment of pathological gambling [abstract]. Presented at the National Institute of Mental Health NCDEU 45th Annual Meeting. Boca Raton, FL: June 6-9, 2005.
42. Rugle L: The use of olanzapine in the treatment of video poker pathological gamblers [abstract]. Presented at The Comorbidity of Pathological Gambling: A Current Research Synthesis conference. Las Vegas: December 3-5.
43. Hodgins DC, Petry NM: Cognitive and behavioral treatments. In Pathological Gambling: A Clinical Guide to Treatment. Edited by Grant JE, Potenza MN. Washington, DC: APPI; 2004.
44. Eucheburua E, Baez C, Fernandez-Montalvo J: Comparative effectiveness of three therapeutic modalities in psychological treatment of pathological gambling: long term outcome. Behav Cog Psychother 1996, 24:51-72.
45. Petry NM: Pathological Gambling: Etiology, Comorbidity, and Treatment. Washington, DC: American Psychological Association; 2005.
46. Petry NM: Gamblers Anonymous and cognitive-behavioral therapies for pathological gamblers. J Gambling Stud 2005, 21:27-33.